TP53 and familial pancreatic carcinoma: Interestingly, MDM2 and β-catenin have both been shown to be overexpressed and constitutively activated in human pancreatic cancer, and the Wnt/β-catenin and MDM2-p53 signaling pathways interact with each other, promoting tumorigenesis and cancer progression and development.